Citizen CH-461C
The technology used in the Citizen CH-461C, to measure blood pressure, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
Accuracy Assessment | Recommendation | Basis | ||
---|---|---|---|---|
Medaval | Legacy approval | Older clinical validation; older protocol | ||
ESH (Europe) | Self-measurement | Published evidence | ||
Japanese Society of Hypertension | Self-measurement (2016-2018, 2020) | Published evidence | ||
Stride BP | Self-measurement for adults | Published evidence |
Broelmann H, Sprenger JC, Faltenbacher VH, Cotte UV, von Willich W, Bogner JR. Validation of two blood pressure measurement devices according to the European Society of Hypertension International Protocol: the Citizen CH-463E and the Citizen CH-461C. Blood Press Monit. 2010 Jun;15(3):158-62. doi: 10.1097/MBP.0b013e328336e9dc. PMID: 20124883.
ESH-IP:2002 - Pass General population